1.Malignant glomus tumor of bone: report of a case.
Kun-kun SUN ; Da-he XIE ; Qiu-jing SONG ; Dan-hua SHEN ; Hua-yi QU ; Song-lin LIAO
Chinese Journal of Pathology 2007;36(3):215-216
Adolescent
;
Bone Neoplasms
;
metabolism
;
pathology
;
surgery
;
Diagnosis, Differential
;
Follow-Up Studies
;
Glomus Tumor
;
metabolism
;
pathology
;
surgery
;
Humans
;
Immunohistochemistry
;
Male
;
Melanoma
;
pathology
;
Proto-Oncogene Proteins c-bcl-2
;
metabolism
;
Tibia
;
metabolism
;
pathology
;
surgery
;
Vimentin
;
metabolism
2.Tumor necrosis factor-related apoptosis-inducing ligand induces glioma U87 cell apoptosis through the mitochondrial apoptotic pathway
Fei ZHONG ; Chun-Kui SHAO ; Jin-Xiang LIN ; Jing YANG ; Xiang-Yuan WU ; Qu LIN ; Ming DONG ; Jing-Yun WEN ; Xiao-Kun MA ; Li WEI
Chinese Journal of Neuromedicine 2008;7(9):878-880,885
Objective To study the mechanism of tumor necrosis factor-related apoptosis-inducing ligand(TRAIL)-induced apoptosis of glioma U87 cells.Methods Human glioma U87 cells were treated with human recombinant soluble TRAIL(rsTRAIL),and the cell apoptosis was detecmd with flow cytometry with AnnexinV-FITC/PI double staining.Flow cytometry with DiOC6 staining was used to assess the changes in mitochondrial transmembrane potential(△ψm).The relative activity of caspase-3,-8 and-9 Was measmed by colorimetric assay,and the concentration of cytoplasmic cytochrome C(cyt C) determined using enzyme-linked immunosorbem assay.The effects ofcaspase-8 inhibitor(Z-IETD-fmk)on rsTRAIL-induced apoptosis,△ψm,caspase-3,-8 and-9 activities and cyt C concentration were observed. Results RsTRAIL tinle-dependently induced apoptosis and progressive collapse of △ψm in glioma U87 cells,resulting also in caspase-3,-8 and-9activation and elevated cytC concentration.Caspase-8 inhibitor partially antagonized these biological effects induced by rsTRAIL in U87 cells.Conclusion TRAIL initiates a cascade of mitochondrial events by activating caspase-8 and induces apoptosis of glioma U87 cells.
3.Expression and analysis of HLA-A, B and DRB1 genes in patients with chronic myelogenous leukemia in Guangdong area.
Li WEI ; Lu-Lu XIAO ; Xiang-Yuan WU ; Qu LIN ; Ming DONG ; Jing-Yun WEN ; Xiao-Kun MA ; Fei CHONG
Journal of Experimental Hematology 2008;16(4):915-918
To study the gene polymorphism of HLA-A, B, DRB1 alleles in patients with chronic myelogenous leukemia and to explore the correlation of HLA with chronic myelogenous leukemia, the polymerase chain reaction-reverse sequence specific oligonucleotide (PCR-RSSO) was used to analyze the polymorphism of HLA-A, B, DRB1 alleles of 293 CML Patients and 406 randomized and synchronous blood donors (healthy and unrelated with patients) from Guangdong Han population. The results indicate that the gene frequency of HLA-A*24 in CML group was 15.53% lower than that of control group (22.09%, RR = 0.63, p = 0.005); the gene frequency of HLA-B*13 in CML group was 10.41% higher than that of control group (6.74%, RR = 1.68, p = 0.016). The gene frequency of HLA- DRB1*14 in CML group was 7.51% lower than that of control group (11.89%, RR = 0.58, p = 0.008). The differences were all statistically significant. It is concluded that the gene frequency of HLA-A*24, HLA- DRB1*14 in CML patients is significantly lower than normal people in Guangdong. The gene frequency of HLA-B*13 in CML patients is significantly higher than normal people in Guangdong. Further study is needed to make sure whether HLA-A*24 and HLA- DRB1*14 are protective gene markers for CML acquisition on Guangdong Chinese Han population and whether HLA-B*13 is a gene marker for CML susceptibility on this population.
Adolescent
;
Adult
;
Aged
;
Blood Donors
;
Child
;
Child, Preschool
;
China
;
Female
;
HLA-A Antigens
;
genetics
;
metabolism
;
HLA-A24 Antigen
;
HLA-B Antigens
;
genetics
;
metabolism
;
HLA-B13 Antigen
;
HLA-DR Antigens
;
genetics
;
metabolism
;
HLA-DRB1 Chains
;
Humans
;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
;
genetics
;
immunology
;
Male
;
Middle Aged
;
Young Adult
4.Etiological characteristics of influenza A (H1N1) 2009 virus in Beijing
Fang HUANG ; Jing GUO ; Shu-Juan CUI ; Yan-Ning LV ; Zhi-Yong GAO ; Wei-Hong LI ; Han-Qiu YAN ; Mei QU ; Wei-Xian SHI ; Gui-Lan LU ; Xin ZHANG ; Dai-Tao ZHANG ; Li-Li TIAN ; Hai-Kun QIAN ; Peng YANG ; Xing-Huo PANG ; Quan-Yi WANG
Chinese Journal of Epidemiology 2010;31(5):494-496
Objective To analyze the results of detection on influenza A (H1N1) 2009 virus in Beijing from May 2009 to December 2009 and to understand the epidemiologic characteristics during the pandemic period. Methods The study was conducted from the May 1 to December 27,2009. A total of 101 852 throat swab samples were detected with the real-time RT-PCR assay by the Beijing Network Laboratory. Data was statistically analyzed. Results 9843 samples showed influenza A (H1N1) 2009 positive, with an overall positive rate as 9.66%. In terms of the positive rates, they were 2.85% from May to June, 3.32% from July to August and 8.35% from September to October. The peak month fell in November (29.67%) and December (24.33%). The positive rates among the following subpopulations were: 8.40% among the suspected cases, 4.75% among close contact cases, 11.46% among the influenza-like illness cases and 7.33% among the cluster cases with fever. Positive cases mainly fell in age groups 5-14 and 15-24. The ratio of male to female was 1.5:1.Conclusion During the pandemic period of influenza A (H1N1) 2009, positive cases gradually increased during May to November but slowly decreasing in December.
5.Global DNA methylation and transcriptional analyses of human ESC-derived cardiomyocytes.
Ying GU ; Guang-Hui LIU ; Nongluk PLONGTHONGKUM ; Christopher BENNER ; Fei YI ; Jing QU ; Keiichiro SUZUKI ; Jiping YANG ; Weiqi ZHANG ; Mo LI ; Nuria MONTSERRAT ; Isaac CRESPO ; Antonio DEL SOL ; Concepcion Rodriguez ESTEBAN ; Kun ZHANG ; Juan Carlos IZPISUA BELMONTE
Protein & Cell 2014;5(1):59-68
With defined culture protocol, human embryonic stem cells (hESCs) are able to generate cardiomyocytes in vitro, therefore providing a great model for human heart development, and holding great potential for cardiac disease therapies. In this study, we successfully generated a highly pure population of human cardiomyocytes (hCMs) (>95% cTnT(+)) from hESC line, which enabled us to identify and characterize an hCM-specific signature, at both the gene expression and DNA methylation levels. Gene functional association network and gene-disease network analyses of these hCM-enriched genes provide new insights into the mechanisms of hCM transcriptional regulation, and stand as an informative and rich resource for investigating cardiac gene functions and disease mechanisms. Moreover, we show that cardiac-structural genes and cardiac-transcription factors have distinct epigenetic mechanisms to regulate their gene expression, providing a better understanding of how the epigenetic machinery coordinates to regulate gene expression in different cell types.
Cell Differentiation
;
Cell Line
;
DNA Methylation
;
Embryonic Stem Cells
;
cytology
;
metabolism
;
Epigenesis, Genetic
;
Gene Expression Profiling
;
Gene Expression Regulation
;
Gene Regulatory Networks
;
Humans
;
Myocytes, Cardiac
;
cytology
;
metabolism
;
Transcription, Genetic
6.Related Factors Affecting Long-term Prognosis of AML Children with Positive RUNX1-RUNX1T1.
Guang-Ying TENG ; Wen-Jing QU ; Kun ZHANG
Journal of Experimental Hematology 2019;27(6):1767-1773
OBJECTIVE:
To analyze the related factors affecting the long-term prognosis of acute myeloid leukemia (AML) children with positive RUNX1-RUNX1T1.
METHODS:
The clinical data of 63 chlidren with positive RUNX1-RUNX1T1 AML treated by BCH-AML 05 regimen in our hospital from January 2010 to December 2015 were collected and analyzed retrospectively. The level of RUNX1-RUNX1T1 was detected at the time of initial diagnosis (T), after the first induction treatment (T), after the second induction treatment (T), after the first consolidation treatment (T), after the second consolidation treatment (T) and after the third consolidation treatment (T). According to the fusion transcript levels of RUNX1-RUNX1T1 the AML children were divided into low-expression group and high-expression group; the threshold values for grouping were 10 copies/10 β-glucuronidase (GUS), 10 copies/10 GUS, 10 copies/10 GUS, 10 copies/10 GUS, 1 copies/10 GUS and 0 copies respectively. The gained data were enrolled in the statistical analysis.
RESULTS:
23 cases of 63 children died during the follow-up period, and the median follow-up time of the remaining 40 children were 30.04 (11-60) months. There were statistically significant differences in CD15 positive rate between low-expression group and high-expression group (P<0.05), however, there were no statistically significant differences in sex, age, FAB typing, platelet (Plt) count, hemoglobin (Hb) and white blood cell (WBC) count and the ratio of bone marrow immature cells at T2 between the two groups (P>0.05). Univariate analysis showed that sex, Plt counts at T and fusion transcript levels at T, T and T correlated with the 5-year overall survival rate (P<0.05). Multivariate analysis showed that fusion transcript level >10 copies/10 GUS at T was an independent risk factor for 5-year overall survival rate (HR=2.13, 95%CI: 1.04-7.78)(P<0.05).
CONCLUSION
The fusion transcript level after the first induction therapy in RUNX1-RUNX1T1-positive AML children is an independent factor influencing the long-term prognosis.
Child
;
Core Binding Factor Alpha 2 Subunit
;
Humans
;
Leukemia, Myeloid, Acute
;
Oncogene Proteins, Fusion
;
Prognosis
;
RUNX1 Translocation Partner 1 Protein
;
Retrospective Studies
7. The Ubiquitin Ligase SMURF1 Catalyzes the Polyubiquitination of ADAR1
Wen-Miao ZHOU ; Hong-Xia WANG ; Jing LIU ; Yu-Liang QU ; Le GUO ; Hong-Xia WANG ; Jing LIU ; Yu-Liang QU ; Le GUO ; Kun-Mei LIU
Chinese Journal of Biochemistry and Molecular Biology 2023;39(11):1630-1637
It is known that SMAD specific E3 ubiquitin protein ligase 1 (SMURF1) mediates autophagy through its E3 ubiquitin ligase activity, but the ubiquitinated substrates of SMURF1 need to be further explored. In this paper, the interacting proteins of SMURF1 in THP-1 cells were captured and identified by co-immunoprecipitation (Co-IP) combined with mass spectrometry. It was found that SMURF1 could physically bind to 222 proteins in THP-1 cells, and Adenosine deaminase acting on RNA 1 (ADAR1) had a higher peptide binding score. SMURF1 overexpression vectors were constructed and transfected into HEK-293T cells, then Co-IP and Western blotting assays verified the interaction between exogenous SMURF1 and endogenous ADAR1. qRT-PCR and Western blotting assays were carried out after transfecting SMURF1 overexpression vectors in HEK-293T cells, which identified that overexpression of SMURF1 attenuated the protein levels of ADAR1 (P<0. 05). However, there was no significant difference in the mRNA level of ADAR1. HEK-293T cells with normal and overexpressing SMURF1 were treated with cycloheximide (CHX), respectively, and Western blotting assays showed a shortened half-life of ADAR1 after overexpression of SMURF1 (P < 0. 05). Furthermore, overexpression of SMURF1 increased the polyubiquitination level of ADAR1 as detected by Co-IP and Western blot (P<0. 05). After the proteasome inhibitor (MG132) treatment, the Western blotting assay was performed to demonstrate that the negative regulatory effect of SMURF1 on ADAR1 was weakened after the proteasome degradation pathway was attenuated (P<0. 05). This study shows that SMURF1 interacts with ADAR1, catalyzes the polyubiquitination of ADAR1 and mediates its degradation through the proteasome pathway, which provides a theoretical basis for exploring the various biological functions of SMURF1 by affecting the stability of ADAR1.
8. Rapid Identification of Alkaloids in Evodia rutaecarpa by HPLC-Q-TOF-MS/MS
Xiao-long HUANG ; Bing-bing SHEN ; Xue-juan LIANG ; Shu-yun SHI ; Du-zhun ZOU ; Yu-ting ZENG ; Jing-kun QU ; Shui-han ZHANG
Chinese Journal of Experimental Traditional Medical Formulae 2019;25(19):102-108
Objective:To obtain the information of alkaloids in Evodia rutaecarpa by HPLC-Q-TOF-MS/MS. Method:Inter Sustain-C18 column (4.6 mm×250 mm,5 μm) was used with 0.2% formic acid water-acetonitrile as the mobile phase for gradient elution. The column temperature was 25℃,the volume flow rate was 1.0 mL·min-1,and the sample volume is 5 μL. The detection wavelength was 245 nm,and the chromatographic effluent was detected and analyzed by using both positive and negative ions. Result:According to molecular ion peaks and secondary mass spectrometry characteristic fragment ions,as well as the mass spectrometry information of reference substances and relevant literature reports,more than 40 major peaks were analyzed,and 21 alkaloids were identified from the methanol extract of E. rutaecarpa, including 10 kinds of indole alkaloids,10 kinds of quinolone alkaloids,and 1 kind of ephedrine. Main types of alkaloids in E. rutaecarpa were basically clarified. And the research found that the alkaloids have a good response mainly in the positive mode. Conclusion:Based on HPLC-Q-TOF-MS/MS technology, high-performance liquid chromatography (HPLC) separation,mass spectrometry determination of molecular mass,pyrolysis data,literature analysis and retrieval were performed to quickly,accurately and comprehensively identify alkaloids in E. rutaecarpa, so as to provide a scientific basis for the further extraction and separation of the chemical constituents of E. rutaecarpa.
9.The efficacy of hemostatic powder for chronic rhinosinusitis in endoscopic sinus surgery: a prospective, randomised, controlled and single blinded clinical trial.
Zhen Xiao HUANG ; Jing QU ; Yu Kun ZHOU ; Yun Xia LI ; Ming Rui HUO ; Cheng LI ; Qian HUANG ; Bing ZHOU ; Yun Chuan LI
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2021;56(2):144-149
Objective: To study the efficacy and patient comfort of absorbable hemostatic powder after endoscopic sinus surgery (ESS). Methods: A total of 21 (17 males, 4 females) patients with an average age of 42(ranging from 18 to 65) underwent bilateral ESS for chronic rhinosinusitis(CRS) in Beijing Tongren Hospital, Capital Medical University between October 2015 and July 2019 were enrolled to compare the effect of absorbable hemostasis powder with Nasopore using an intrapatient control design. A randomized controlled trial was conducted in the left and right nasal cavities of the same patient. If hemostatic powder was applied in the experiment nasal cavity, the Nasopore was applied in the control nasal cavity. The mean preoperative sinus computed tomography (CT) score was 6.25. All patients competed for symptom diaries using a visual analog scale (VAS, score out of 10) at baseline, through 1, 7, 14 and 30 days. Outcomes including bleeding, facial pain, nasal obstruction, nasal discharges using VAS were recorded separately for both sides. Postoperative endoscopic scores were also investigated. SPSS 22 and Graphpad prism 8.0 statistical softwares were used for the analysis. Paired t-test or nonparametric test was used between the test side and the control side. The difference was statistically significant (P<0.05). Results: The bleeding score and total nasal symptom VAS scores at postoperative days (POD) 1, 7, 14 and 30 were not significantly different(t=1.341, 0.552, 0.631, 0.158, all P>0.05;t=0.944, 1.471, 1.612, 2.251, all P>0.05). There was no significant difference between absorbable hemostasis powder and Nasopore side on POD 1, 7, 14 and 30 in terms of each nasal symptom VAS scores(all P>0.05). On POD 1, 7 and 14, the packing material degeneration scores of the absorbable hemostasis powder side were significantly lower than those of the Nasopore side [(1.33±0.21)vs(2.00±0.00),(0.38±0.18) vs (1.95±0.22), 0 vs (1.80±0.13), all P<0.01]. There were significant differences between absorbable hemostasis powder and Nasopore side on POD 1, 7, 14 and 30 in terms of endoscopic scores (edema, crusting, discharges, scar, polyps and material degeneration, t=3.07, 7.00, 6.41, 2.69, all P<0.05). Conclusions: The absorbable hemostasis powder and Nasopore has similar postoperative hemostasis effect. The absorbable hemostasis powder is rapidly cleared and without negative effects on mucosal wound healing 14 days postoperatively.
10.Pathway of Diatoms Enter Experimental Rabbits through the Lymphatic System of the Digestive Tract.
Yu-Kun DU ; Jing-Jian LIU ; Xiao-Dong KANG ; Zhong-Hao YU ; Dong-Yun ZHENG ; He SHI ; Qu-Yi XU ; Jian-Jun REN ; Chao LIU ; Jian ZHAO
Journal of Forensic Medicine 2022;38(1):67-70
OBJECTIVES:
To study whether diatoms can enter the body through the lymphatic system of the digestive tract.
METHODS:
Twenty experimental rabbits were divided into the test group and the control group randomly, and intragastric administration was performed with 20 mL water sample from the Pearl River and 20 mL ultrapure water, respectively. After 30 min, lymph, lungs, livers and kidneys were extracted for the diatom test. The concentration, size and type of diatoms were recorded.
RESULTS:
The concentration of diatoms of the test group was higher than that of the control group (P<0.05). In the test group, Stephanodiscus, Coscinodiscus, Cyclotella, Melosira, Nitzschia, Synedra, Cymbella, and Navicula were detected; in the control group, Stephanodiscus, Coscinodiscus and Cyclotella were detected. The long diameter and the short diameter of diatoms of the test group were higher than those of the control group (P<0.05). In the test group, 1-2 diatoms were detected in 3 lung samples and 2 liver samples, which were Stephanodiscus or Cyclotella, and no diatoms were detected in the kidney samples; in the control group, 1-2 diatoms were detected in 2 lung samples and 3 liver samples, which were Stephanodiscus or Coscinodiscus, and no diatoms were detected in the kidney samples.
CONCLUSIONS
Diatoms can enter the body through the lymphatic fluid, which is one of the reasons for the presence of diatoms in tissues and organs of non-drowning cadavers.
Animals
;
Diatoms
;
Drowning
;
Gastrointestinal Tract
;
Lung
;
Lymphatic System
;
Rabbits
;
Water/metabolism*